Get started

Financials · YCBD

cbdMD Inc. (YCBD) financials

For the twelve months ended Jun 30, 2026, cbdMD Inc. reported $20.93M of revenue and -$2.89M of net income.

Revenue, TTM
$20.93M
Revenue growth, YoY
+10.0%
Net income, TTM
-$2.89M
Net margin
-13.8%
Free cash flow, TTM
-$2.41M
Cash
$2.12M
P/S
0.24
Market cap
$5.1M
Annual revenue$19.19M
FY2016FY2025
Annual net income-$2.04M
FY2016FY2025
Annual free cash flow-$1.64M
FY2016FY2025

YCBD revenue and earnings growth

YCBD revenueQ3 2026$5.55M

Quarter YoY
+20.6%
QoQ
-1.5%
FY YoY
-3.7%
5Y CAGR
-14.5%

YCBD revenue was $5.55M in fiscal Q3 2026 (ended Jun 30, 2026), up 20.6% from a year earlier and down 1.5% from the prior quarter. For the full fiscal 2025 it was $19.19M, down 3.7% from fiscal 2024. Compound annual growth was -14.5% over 5 years. It rose in 4 of the last 9 fiscal years.

YCBD net incomeQ3 2026-$1.13M

YCBD net income was -$1.13M in fiscal Q3 2026 (ended Jun 30, 2026), compared with -$895.3K a year earlier. For the full fiscal 2025 it was -$2.04M, compared with -$3.70M in fiscal 2024.

YCBD EPSFY2025-$1.09

YCBD diluted EPS was -$1.09 for fiscal 2025 (ended Sep 30, 2025).

YCBD free cash flowQ3 2026-$460.2K

YCBD free cash flow was -$460.2K in fiscal Q3 2026 (ended Jun 30, 2026), compared with -$705.7K a year earlier. For the full fiscal 2025 it was -$1.64M, compared with -$542.8K in fiscal 2024.

Export CSV

Income statement

Income statement
Line item
FY2025
Sep 30, 2025
FY2024
Sep 30, 2024
FY2023
Sep 30, 2023
FY2022
Sep 30, 2022
FY2021
Sep 30, 2021
FY2020
Sep 30, 2020
FY2019
Sep 30, 2019
FY2018
Sep 30, 2018
FY2017
Sep 30, 2017
FY2016
Sep 30, 2016
Revenue$19.19M$19.92M$25.05M$37.12M$47.33M$41.88M$23.65M$459.1K$4.47M$2.03M
Cost of revenue$7.22M$7.49M$9.18M$13.07M$14.50M$15.51M$9.14M$104.0K$1.36M$1.62M
Gross profit$11.97M$12.00M$14.98M$22.34M$29.99M$26.37M$14.51M$355.1K$3.12M$413.1K
Operating income-$2.16M-$3.32M-$22.49M-$78.27M-$19.62M-$17.58M-$14.80M-$1.80M-$1.36M-$3.89M
Interest expense-------$955$500.6K$155.0K
Pre-tax income-$2.04M-$3.70M-$22.94M-$70.08M-$24.29M$11.31M-$47.79M-$1.80M--
Income tax$0$0$0$0-$895.0K$1.35M-$2.36M$0$25.0K$8.0K
Net income-$2.04M-$3.70M-$22.94M-$70.08M-$23.39M$12.60M-$51.36M$62.8K-$1.39M-$3.90M
EPS, basic-$1.09-$14.29-$106.56-$446.40-$169.20$100.80-$1015.20-$18.00-$136.80-$406.80
EPS, diluted-$1.09-$14.29-$106.56-$446.40-$169.20$100.80$0.00$0.00-$136.80-$406.80
Diluted shares4.0M539,069252,790165,973152,605.911125,476.87249,686.79721,527.61712,569.4038,278.397

Balance sheet

Balance sheet
Line item
FY2025
Sep 30, 2025
FY2024
Sep 30, 2024
FY2023
Sep 30, 2023
FY2022
Sep 30, 2022
FY2021
Sep 30, 2021
FY2020
Sep 30, 2020
FY2019
Sep 30, 2019
FY2018
Sep 30, 2018
FY2017
Sep 30, 2017
FY2016
Sep 30, 2016
Cash and equivalents$2.26M$2.45M$1.80M$6.72M$26.41M$14.82M$4.69M$4.28M$284.2K$34.3K
Short-term investments---$0$33.4K$26.5K$198.5K$1.05M$0-
Receivables$786.4K$621.7K$1.22M$273.5K--$0$459.0K$0-
Inventory$2.95M$2.52M$4.24M$4.77M$5.57M$4.89M$5.21M$123.2K$588.2K$614.2K
Current assets$6.55M$6.39M$8.07M$16.01M$36.50M$23.71M$15.74M$11.79M$3.69M$956.3K
Goodwill$0-$0$0$56.67M$54.67M$54.67M$0--
Total assets$10.42M$10.58M$16.20M$40.79M$124.88M$110.84M$94.52M$15.02M$7.07M$1.62M
Current liabilities$3.19M$8.62M$4.67M$5.29M$6.92M$7.69M$3.71M$970.0K$1.52M$1.90M
Long-term debt--$0$125.5K$109.0K$264.4K----
Total debt--$0$125.5K$109.0K$264.4K----
Total liabilities$3.19M$8.62M$7.16M$9.37M$21.74M$31.66M$56.91M$998.5K$1.92M$1.92M
Shareholders' equity$7.23M$1.96M$9.03M$31.42M$103.14M$79.18M$37.60M$14.02M$5.15M-$292.7K

Cash flow

Cash flow
Line item
FY2025
Sep 30, 2025
FY2024
Sep 30, 2024
FY2023
Sep 30, 2023
FY2022
Sep 30, 2022
FY2021
Sep 30, 2021
FY2020
Sep 30, 2020
FY2019
Sep 30, 2019
FY2018
Sep 30, 2018
FY2017
Sep 30, 2017
FY2016
Sep 30, 2016
Operating cash flow-$1.45M-$352.8K-$4.30M-$14.97M-$14.09M-$10.66M-$15.38M-$5.57M-$2.33M-$2.90M
Capital expenditures$184.2K$190.0K$297.5K$688.7K$342.0K$1.32M$1.20M$23.6K$8.0K$127.3K
Free cash flow-$1.64M-$542.8K-$4.60M-$15.66M-$14.44M-$11.98M-$16.58M-$5.60M-$2.34M-$3.02M
Investing cash flow-$184.2K-$290.0K$702.5K-$688.7K-$2.55M-$1.57M-$2.13M-$683.6K$192.0K-$127.3K
Financing cash flow$1.45M$1.30M-$1.32M-$4.04M$28.23M$22.37M$17.92M$10.25M$2.39M$2.51M
Dividends paid----$2.55M$366.9K$0---
Stock-based compensation----$1.30M$1.90M$2.46M$639.6K$56.5K$11.4K
Depreciation and amortization----$1.02M$720.8K$289.6K$222.5K$71.3K$44.9K

Key ratios

Key ratios
Line item
FY2025
Sep 30, 2025
FY2024
Sep 30, 2024
FY2023
Sep 30, 2023
FY2022
Sep 30, 2022
FY2021
Sep 30, 2021
FY2020
Sep 30, 2020
FY2019
Sep 30, 2019
FY2018
Sep 30, 2018
FY2017
Sep 30, 2017
FY2016
Sep 30, 2016
Revenue growth, YoY-3.7%-20.5%-32.5%-21.6%13.0%77.1%5051.8%-89.7%120.3%-
Gross margin62.4%60.2%59.8%60.2%63.4%63.0%61.4%77.3%69.7%20.3%
Operating margin-11.3%-16.6%-89.8%-210.8%-41.4%-42.0%-62.6%-391.4%-30.4%-191.4%
Net margin-10.6%-18.6%-91.6%-188.8%-49.4%30.1%-217.1%13.7%-31.0%-191.8%
Free cash flow margin-8.5%-2.7%-18.4%-42.2%-30.5%-28.6%-70.1%-1219.1%-52.2%-148.9%
Return on equity-28.2%-188.5%-254.0%-223.0%-22.7%15.9%-136.6%0.4%-26.9%-
Return on assets-19.6%-35.0%-141.6%-171.8%-18.7%11.4%-54.3%0.4%-19.6%-240.0%
Current ratio2.050.741.733.035.283.084.2412.162.420.50
Debt to equity--0.000.000.000.00----

Source: XBRL data cbdMD Inc. files with the SEC, latest filing dated Aug 13, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures and share counts are restated for stock splits the filings show: 1-for-45, first reported May 15, 2023; 1-for-8, first reported Dec 19, 2025.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

YCBD peers

CompanyRevenueGrowthNet incomeNet marginMarket cap
YCBD$20.93M+10.0%-$2.89M-13.8%$5.1M
PG$87.92B+3.5%$16.03B18.2%$390.13B
UL€50.50B-3.8%€9.47B18.7%$143.50B
ECL$17.37B+9.3%$2.08B12.0%$86.03B
CL$21.28B+5.9%$2.05B9.6%$77.85B
EL$15.28B+5.8%$368.00M2.4%$41.00B
HLN£11.03B-1.8%£1.67B15.1%$39.43B
KVUE$15.53B+3.5%$1.69B10.9%$37.57B
CHD$6.25B+1.7%$774.80M12.4%$26.27B

YCBD FAQ

8 questions
  • What is YCBD revenue?
    cbdMD Inc. (YCBD) reported $20.93M of revenue for the twelve months ended Jun 30, 2026. That is up 10.0% from the year before. Revenue for fiscal 2025 was $19.19M.
  • Is YCBD profitable?
    No. cbdMD Inc. reported a net loss of $2.89M for the twelve months ended Jun 30, 2026.
  • How much cash and debt does YCBD have?
    cbdMD Inc. reported $2.12M in cash and cash equivalents on its most recent balance sheet in SEC filings.
  • How fast is YCBD revenue growing?
    cbdMD Inc.'s revenue changed -3.7% in fiscal 2025, to $19.19M. Its compound annual growth rate was -14.5% over 5 years.
  • What is YCBD gross margin?
    cbdMD Inc.'s gross profit was $12.07M on $20.93M of revenue for the twelve months ended Jun 30, 2026, a gross margin of 57.7%.
  • What is YCBD free cash flow?
    cbdMD Inc. generated -$2.41M of free cash flow for the twelve months ended Jun 30, 2026, which is operating cash flow of -$2.22M less capital expenditures.
  • When did YCBD last report financial results?
    The latest statements here come from cbdMD Inc.'s 10-Q filed on Aug 13, 2026, covering the period ended Jun 30, 2026.
  • Where does this YCBD financial data come from?
    Quantisnow builds these statements from the structured XBRL data cbdMD Inc. files with the SEC. It is provided for information only and is not investment advice.